An invalid vocabulary is selected. Please change it in the options.
Title Creditssort descending Start date - Expiration date
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Pediatric Acute Lymphoblastic Leukemia (ALL) 1.00 09/12/2019 - 12:00am to 09/12/2020 - 12:00am
New Approaches to Multiple Myeloma Therapy 1.00 05/12/2020 - 12:00am to 05/12/2021 - 12:00am
Recorded Presentation from the NCCN Pharmacy Updates: Emerging Strategies for Pediatric Acute Lymphoblastic Leukemia Management 1.00 01/31/2020 - 12:00am to 01/28/2021 - 12:00am
NCCN Guidelines® Insights - Primary Cutaneous Lymphomas, Version 2.2020 1.00 05/10/2020 - 12:00am to 05/10/2021 - 12:00am
NCCN Guidelines® Insights - Kidney Cancer, Version 2.2020 1.00 11/10/2019 - 12:00am to 11/10/2020 - 12:00am
Recognition and Management of Graft Versus Host Disease 1.00 05/12/2020 - 12:00am to 03/01/2021 - 12:00am
Recorded Presentation from the NCCN Oncology Case Manager and Medical Director Program: Updates in the Treatment of HER-2 Positive Breast Cancer 1.04 10/18/2019 - 12:00am to 10/18/2020 - 12:00am
Recorded Presentation from the NCCN Oncology Case Manager and Medical Director Program: New Treatments for Metastatic Lung Cancer 1.08 12/23/2019 - 12:00am to 12/23/2020 - 12:00am
Immunotherapies in Non-Small Cell Lung Cancer 1.25 12/17/2019 - 12:00am to 12/17/2020 - 12:00am
New Targeted Therapies for Non-Small Cell Lung Cancer 1.25 12/17/2019 - 12:00am to 12/17/2020 - 12:00am
Recorded Presentation from the NCCN Oncology Case Manager and Medical Director Program: Managing Cancer Pain in the U.S. Opioid Crisis 1.25 12/16/2019 - 12:00am to 12/16/2020 - 12:00am
Current Insights: Evolving Principles and Controversies of Cancer Risk Assessment and Management of Hereditary Cancers 1.25 05/15/2020 - 12:00am to 03/01/2021 - 12:00am
Role of Biosimilars in the Oncology Ecosystem 1.25 05/15/2020 - 12:00am to 03/01/2021 - 12:00am
Recorded Presentation from the NCCN Oncology Case Manager and Medical Director Program: Updates in the Treatment of Follicular Lymphoma and Diffuse... 1.25 11/05/2019 - 12:00am to 11/05/2020 - 12:00am
Debate - What is Optimal First-Line Therapy for Chronic Lymphocytic Leukemia: Chemoimmunotherapy or Small Molecule Inhibitor Therapy? 1.25 05/18/2020 - 12:00am to 03/01/2021 - 12:00am

Pages